CAS 141595-53-1

N,N-esametilenocarbamoil-leu-N-*formil-D-trp-D-

Descrizione:

N,N-esametilenocarbamoilo-leu-N-formilo-D-triptofano (CAS 141595-53-1) è un composto sintetico che appartiene alla classe dei derivati peptidici. Presenta una catena di esametilene che collega un gruppo carbamoile a un residuo di leucina, insieme a una porzione di D-triptofano formilato. Questa struttura suggerisce che potrebbe mostrare proprietà tipiche dei peptidi, come potenziale attività biologica e interazioni con recettori o enzimi specifici. La presenza del gruppo formile può influenzare la sua reattività e solubilità, mentre la configurazione dell'aminoacido D può influenzare la sua stabilità e resistenza alla degradazione enzimatica. Il composto è probabilmente di interesse nella ricerca biochimica, in particolare negli studi relativi alla sintesi di peptidi, progettazione di farmaci o come potenziale agente terapeutico. Le sue caratteristiche specifiche, come solubilità, punto di fusione e attività biologica, richiederebbero un'indagine empirica per comprendere appieno il suo comportamento in vari ambienti.

Formula: C₃₆H₄₄N₆O₆

InChI: InChI=1/C36H44N6O6/c1-23(2)17-29(40-36(48)41-15-9-3-4-10-16-41)33(44)38-30(19-25-21-42(22-43)32-14-8-6-12-27(25)32)34(45)39-31(35(46)47)18-24-20-37-28-13-7-5-11-26(24)28/h5-8,11-14,20-23,29-31,37H,3-4,9-10,15-19H2,1-2H3,(H,38,44)(H,39,45)(H,40,48)(H,46,47)/t29-,30+,31+/m0/s1

Sinonimi:

• N-(azepan-1-ylcarbonyl)-L-leucyl-1-formyl-D-tryptophyl-D-tryptophan
• Bq-610

BQ-610

CAS: 141595-53-1

BQ-610 is a very potent ET-A receptor antagonist which is about 30000 times more selective for ET-A receptors than for ET-B receptors. Furthermore, it has been found that BQ-610 strongly antagonizes ET-1 induced concentration in porcine coronary artery with a pA₂ value of 8.2.

Formula: C₃₆H₄₄N₆O₆

Purezza: > 95%

Peso molecolare: 656.78

Ref: 01-4034542

D-Tryptophan, N-[(hexahydro-1H-azepin-1-yl)carbonyl]-L-leucyl-1-formyl-D-tryptophyl-

CAS: 141595-53-1

Formula: C₃₆H₄₄N₆O₆

Peso molecolare: 656.7712

Ref: IN-DA001GNK

BQ-610

CAS: 141595-53-1

BQ-610 is a drug that has been shown to improve brain functions and energy metabolism. It also inhibits the transmission of pain signals in the mesenteric region of rats by blocking voltage-dependent calcium channels. BQ-610 is found to suppress the production of endothelin-a receptor, which is an important regulator for many diseases such as infectious diseases, hypertension, and other cardiovascular disorders. The drug has also been shown to reduce oxidative stress by inhibiting cell nuclei and reducing inflammation by inhibiting basic protein synthesis. BQ-610 has been shown to be effective against congestive heart failure in rats by increasing blood flow and improving biochemical properties.

Formula: C₃₆H₄₄N₆O₆

Purezza: Min. 95%

Peso molecolare: 656.79 g/mol

Ref: 3D-PED-3610-PI

BQ-610

CAS: 141595-53-1

BQ-610 is an Endothelin A receptor antagonist.

Formula: C₃₆H₄₄N₆O₆

Colore e forma: Solid

Peso molecolare: 656.77

Ref: TM-T70727

BQ-610 Azepane-1-carbonyl-Leu-D-Trp(For)-D-Trp-OH

CAS: 141595-53-1

BQ-610 is a novel peptide that has been shown to reduce the severity of mucosal inflammation in animal models of inflammatory bowel disease. It functions by binding to myofibroblasts, which are cells that produce an extracellular matrix and collagen. BQ-610 also blocks signalling pathways that are responsible for the production of TNF-α, MMP-2, and other molecules involved in the pathogenesis of inflammatory bowel disease. BQ-610 is effective at reducing inflammation in animal models of colitis, but not in human colonic epithelial cells or human colonic tissue.

Formula: C₃₆H₄₄N₆O₆

Purezza: Min. 95%

Peso molecolare: 656.77 g/mol

Ref: 3D-FB109401